[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100598448":3},{"organization":4,"outcomesModule":7,"designInfo":20,"detailedDescription":19,"studyPopulation":19,"armGroups":31,"interventions":46,"overallOfficials":66,"centralContacts":70,"locations":76,"responsibleParty":397,"collaborators":19,"id":399,"slug":400,"hasResults":401,"nctId":402,"briefTitle":403,"officialTitle":404,"acronym":19,"eligibilityCriteria":405,"healthyVolunteers":406,"sex":407,"minAge":408,"maxAge":409,"enrollmentInfo":410,"targetDuration":19,"studyType":413,"phases":414,"briefSummary":416,"conditions":417,"keywords":19,"overallStatus":79,"whyStopped":19,"lastUpdateSubmitDate":420,"lastUpdatePostDateStruct":421,"startDateStruct":424,"completionDateStruct":426,"leadSponsor":428,"locationsCount":429},{"fullName":5,"class":6},"Merck Sharp & Dohme LLC","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":19},[9,13,16],{"measure":10,"description":11,"timeFrame":12},"Number of Participants with Adjudicated Human Immunodeficiency Virus Type 1 (HIV-1) Infection","The number of participants with adjudicated HIV-1 infection will be presented.","Up to ~2 years",{"measure":14,"description":15,"timeFrame":12},"Number of Participants who Experience At Least One Adverse Event (AE)","An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants that experienced AEs will be presented.",{"measure":17,"description":18,"timeFrame":12},"Number of Participants who Discontinue Study Intervention Due to an AE","An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants that discontinued study intervention due to an AE will be presented.",null,{"allocation":21,"interventionModel":22,"interventionModelDescription":19,"primaryPurpose":23,"observationalModel":19,"timePerspective":19,"maskingInfo":24},"RANDOMIZED","PARALLEL","PREVENTION",{"masking":25,"maskingDescription":19,"whoMasked":26},"QUADRUPLE",[27,28,29,30],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR",[32,39],{"label":33,"type":34,"description":35,"interventionNames":36},"MK-8527 + Placebo to FTC\u002FTDF","EXPERIMENTAL","Participants will receive 11 mg MK-8527 once monthly (QM) and placebo matched to Emtricitabine\u002FTenofovir Disoproxil Fumarate (FTC\u002FTDF) once daily (QD) for up to approximately 2 years. Participants will then receive open-label 200 mg FTC\u002F245 mg TDF QD for an additional 28 days.",[37,38],"Drug: MK-8527","Drug: Placebo matched to FTC\u002FTDF",{"label":40,"type":41,"description":42,"interventionNames":43},"FTC\u002FTDF + Placebo to MK-8527","ACTIVE_COMPARATOR","Participants will receive 200 mg FTC\u002F245 mg TDF QD and placebo matched to MK-8527 QM for up to approximately 2 years. Participants will then receive open-label 200 mg FTC\u002F245 mg TDF QD for an additional 28 days.",[44,45],"Drug: Emtricitabine\u002Ftenofovir disoproxil (FTC\u002FTDF)","Drug: Placebo matched to MK-8527",[47,52,58,62],{"type":48,"name":49,"description":50,"armGroupLabels":51,"otherNames":19},"DRUG","MK-8527","Oral tablet",[33],{"type":48,"name":53,"description":50,"armGroupLabels":54,"otherNames":55},"Emtricitabine\u002Ftenofovir disoproxil (FTC\u002FTDF)",[40],[56,57],"Truvada","Emtricitabine\u002FTenofovir Disoproxil Fumarate",{"type":48,"name":59,"description":60,"armGroupLabels":61,"otherNames":19},"Placebo matched to MK-8527","Placebo oral tablet matched to MK-8527",[40],{"type":48,"name":63,"description":64,"armGroupLabels":65,"otherNames":19},"Placebo matched to FTC\u002FTDF","Placebo oral tablet matched to FTC\u002FTDF",[33],[67],{"name":68,"affiliation":5,"role":69},"Medical Director","STUDY_DIRECTOR",[71],{"name":72,"role":73,"phone":74,"phoneExt":19,"email":75},"Toll Free Number","CONTACT","1-888-577-8839","Trialsites@msd.com",[77,89,96,104,117,132,142,155,168,177,184,196,206,218,227,235,244,256,268,280,292,299,311,324,330,339,354,362,375,385],{"facility":78,"status":79,"city":80,"state":81,"zip":82,"country":83,"countryCode":84,"cosmosGeoPoint":19,"geoPoint":19,"contacts":85},"UW - KNH; Rachuonyo County Hospital ( Site 0006)","RECRUITING","Homabay County","Homa Bay County","40222","Kenya","KE",[86],{"name":87,"role":73,"phone":88,"phoneExt":19,"email":19},"Study Coordinator","+254723479756",{"facility":90,"status":79,"city":91,"state":92,"zip":93,"country":83,"countryCode":84,"cosmosGeoPoint":19,"geoPoint":19,"contacts":94},"Partners in Health and Research Development (PHRD) ( Site 0002)","Thika","Kiambu County","00202",[95],{"name":87,"role":73,"phone":74,"phoneExt":19,"email":19},{"facility":97,"status":79,"city":98,"state":99,"zip":100,"country":83,"countryCode":84,"cosmosGeoPoint":19,"geoPoint":19,"contacts":101},"KEMRI-CMR-RCTP ( Site 0003)","Nairobi","Kisumu County","00200",[102],{"name":87,"role":73,"phone":103,"phoneExt":19,"email":19},"+254202600017",{"facility":105,"status":79,"city":106,"state":19,"zip":107,"country":83,"countryCode":84,"cosmosGeoPoint":108,"geoPoint":113,"contacts":114},"Kargeno Research & Policy Hub ( Site 0007)","Kisumu","40123",{"type":109,"coordinates":110},"Point",[111,112],34.76171,-0.10221,{"lat":112,"lon":111},[115],{"name":87,"role":73,"phone":116,"phoneExt":19,"email":19},"+254732390992",{"facility":118,"status":79,"city":119,"state":120,"zip":121,"country":122,"countryCode":123,"cosmosGeoPoint":124,"geoPoint":128,"contacts":129},"Synergy Biomed Research Institute ( Site 0040)","East London","Eastern Cape","5241","South Africa","ZA",{"type":109,"coordinates":125},[126,127],27.91162,-33.01529,{"lat":127,"lon":126},[130],{"name":87,"role":73,"phone":131,"phoneExt":19,"email":19},"+27437222306",{"facility":133,"status":134,"city":135,"state":120,"zip":136,"country":122,"countryCode":123,"cosmosGeoPoint":137,"geoPoint":141,"contacts":19},"Foundation For Professional Development ( Site 0031)","ACTIVE_NOT_RECRUITING","Ndevana","5660",{"type":109,"coordinates":138},[139,140],27.50973,-32.90769,{"lat":140,"lon":139},{"facility":143,"status":79,"city":144,"state":145,"zip":146,"country":122,"countryCode":123,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"Josha Research ( Site 0045)","Bloemfontein","Free State","9301",{"type":109,"coordinates":148},[149,150],26.214,-29.12107,{"lat":150,"lon":149},[153],{"name":87,"role":73,"phone":154,"phoneExt":19,"email":19},"+27 51 412 8160",{"facility":156,"status":79,"city":157,"state":158,"zip":159,"country":122,"countryCode":123,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"Wits RHI Ward 21 Clinical Research site ( Site 0022)","Johannesburg","Gauteng","2001",{"type":109,"coordinates":161},[162,163],28.04363,-26.20227,{"lat":163,"lon":162},[166],{"name":87,"role":73,"phone":167,"phoneExt":19,"email":19},"+27823776275",{"facility":169,"status":79,"city":157,"state":158,"zip":170,"country":122,"countryCode":123,"cosmosGeoPoint":171,"geoPoint":173,"contacts":174},"Helen Joseph Hospital-Clinical HIV Research Unit ( Site 0048)","2092",{"type":109,"coordinates":172},[162,163],{"lat":163,"lon":162},[175],{"name":87,"role":73,"phone":176,"phoneExt":19,"email":19},"+27112768800",{"facility":178,"status":79,"city":179,"state":158,"zip":180,"country":122,"countryCode":123,"cosmosGeoPoint":19,"geoPoint":19,"contacts":181},"Perinatal HIV Research Unit (PHRU) ( Site 0033)","Johnnesburg","1864",[182],{"name":87,"role":73,"phone":183,"phoneExt":19,"email":19},"+27 11 989 9711",{"facility":185,"status":79,"city":186,"state":158,"zip":187,"country":122,"countryCode":123,"cosmosGeoPoint":188,"geoPoint":192,"contacts":193},"Setshaba Research Centre ( Site 0032)","Pretoria","0152",{"type":109,"coordinates":189},[190,191],28.18783,-25.74486,{"lat":191,"lon":190},[194],{"name":87,"role":73,"phone":195,"phoneExt":19,"email":19},"0127992422",{"facility":197,"status":134,"city":198,"state":199,"zip":200,"country":122,"countryCode":123,"cosmosGeoPoint":201,"geoPoint":205,"contacts":19},"SA Medical Research Council - Chatsworth Clinical Research Site ( Site 0026)","Chatsworth","KwaZulu-Natal","4092",{"type":109,"coordinates":202},[203,204],30.8917,-29.91866,{"lat":204,"lon":203},{"facility":207,"status":79,"city":208,"state":199,"zip":209,"country":122,"countryCode":123,"cosmosGeoPoint":210,"geoPoint":214,"contacts":215},"SA Medical Research Council - Botha's Hill Clinical Research Site ( Site 0035)","Durban","3660",{"type":109,"coordinates":211},[212,213],31.0292,-29.8579,{"lat":213,"lon":212},[216],{"name":87,"role":73,"phone":217,"phoneExt":19,"email":19},"+27312423647",{"facility":219,"status":79,"city":208,"state":199,"zip":220,"country":122,"countryCode":123,"cosmosGeoPoint":221,"geoPoint":223,"contacts":224},"CAPRISA eThekwini Clinical Research Site ( Site 0030)","4001",{"type":109,"coordinates":222},[212,213],{"lat":213,"lon":212},[225],{"name":87,"role":73,"phone":226,"phoneExt":19,"email":19},"+27312601961",{"facility":228,"status":79,"city":208,"state":199,"zip":220,"country":122,"countryCode":123,"cosmosGeoPoint":229,"geoPoint":231,"contacts":232},"Wits Maternal Adolescent and Child Health Research Unit (WMRU) ( Site 0027)",{"type":109,"coordinates":230},[212,213],{"lat":213,"lon":212},[233],{"name":87,"role":73,"phone":234,"phoneExt":19,"email":19},"+27 31 001 1900",{"facility":236,"status":79,"city":208,"state":199,"zip":237,"country":122,"countryCode":123,"cosmosGeoPoint":238,"geoPoint":240,"contacts":241},"Umlazi Clinical Research Site ( Site 0047)","4089",{"type":109,"coordinates":239},[212,213],{"lat":213,"lon":212},[242],{"name":87,"role":73,"phone":243,"phoneExt":19,"email":19},"+2731 260 1982",{"facility":245,"status":79,"city":246,"state":199,"zip":247,"country":122,"countryCode":123,"cosmosGeoPoint":248,"geoPoint":252,"contacts":253},"SYNAPSE Research Clinic ( Site 0043)","Edendale","3216",{"type":109,"coordinates":249},[250,251],30.31498,-29.65247,{"lat":251,"lon":250},[254],{"name":87,"role":73,"phone":255,"phoneExt":19,"email":19},"+27 73 297 2172",{"facility":257,"status":79,"city":258,"state":199,"zip":259,"country":122,"countryCode":123,"cosmosGeoPoint":260,"geoPoint":264,"contacts":265},"Qhakaza Mbokodo Research Clinic ( Site 0028)","Ladysmith","3370",{"type":109,"coordinates":261},[262,263],29.77896,-28.55874,{"lat":263,"lon":262},[266],{"name":87,"role":73,"phone":267,"phoneExt":19,"email":19},"+27366312372",{"facility":269,"status":79,"city":270,"state":199,"zip":271,"country":122,"countryCode":123,"cosmosGeoPoint":272,"geoPoint":276,"contacts":277},"SA Medical Research Council - Phoenix Clinical Research Site ( Site 0037)","Phoenix","4068",{"type":109,"coordinates":273},[274,275],31.0051,-29.70306,{"lat":275,"lon":274},[278],{"name":87,"role":73,"phone":279,"phoneExt":19,"email":19},"+27312423632",{"facility":281,"status":79,"city":282,"state":199,"zip":283,"country":122,"countryCode":123,"cosmosGeoPoint":284,"geoPoint":288,"contacts":289},"CAPRISA Vulindlela Clinical Research Site ( Site 0029)","Pietermaritzburg","3231",{"type":109,"coordinates":285},[286,287],30.39278,-29.61679,{"lat":287,"lon":286},[290],{"name":87,"role":73,"phone":291,"phoneExt":19,"email":19},"+2731 655 0694",{"facility":293,"status":79,"city":294,"state":199,"zip":295,"country":122,"countryCode":123,"cosmosGeoPoint":19,"geoPoint":19,"contacts":296},"Africa Health Research Institute (AHRI) - Mtubatuba ( Site 0049)","Somkhele - Mtubatuba","3935",[297],{"name":87,"role":73,"phone":298,"phoneExt":19,"email":19},"+27 35 251 0900",{"facility":300,"status":79,"city":301,"state":199,"zip":302,"country":122,"countryCode":123,"cosmosGeoPoint":303,"geoPoint":307,"contacts":308},"SA Medical Research Council - Verulam Clinical Research Site ( Site 0036)","Verulam","4340",{"type":109,"coordinates":304},[305,306],31.04709,-29.6434,{"lat":306,"lon":305},[309],{"name":87,"role":73,"phone":310,"phoneExt":19,"email":19},"+27325334145",{"facility":312,"status":79,"city":313,"state":314,"zip":315,"country":122,"countryCode":123,"cosmosGeoPoint":316,"geoPoint":320,"contacts":321},"Desmond Tutu Health Foundation. Philippi Village ( Site 0024)","Cape Town","Western Cape","7781",{"type":109,"coordinates":317},[318,319],18.42322,-33.92584,{"lat":319,"lon":318},[322],{"name":87,"role":73,"phone":323,"phoneExt":19,"email":19},"+27870572508",{"facility":325,"status":134,"city":313,"state":314,"zip":326,"country":122,"countryCode":123,"cosmosGeoPoint":327,"geoPoint":329,"contacts":19},"DTHF Masiphumelele Clinical Research Site ( Site 0023)","7975",{"type":109,"coordinates":328},[318,319],{"lat":319,"lon":318},{"facility":331,"status":134,"city":332,"state":314,"zip":333,"country":122,"countryCode":123,"cosmosGeoPoint":334,"geoPoint":338,"contacts":19},"Vuka Research Clinic ( Site 0025)","Khayelitsha","7784",{"type":109,"coordinates":335},[336,337],18.67916,-34.03932,{"lat":337,"lon":336},{"facility":340,"status":79,"city":341,"state":342,"zip":343,"country":344,"countryCode":345,"cosmosGeoPoint":346,"geoPoint":350,"contacts":351},"MRC\u002FUVRI and LSHTM Uganda Research Unit Masaka ( Site 0064)","Entebbe","Central Region","256","Uganda","UG",{"type":109,"coordinates":347},[348,349],32.47949,0.05621,{"lat":349,"lon":348},[352],{"name":87,"role":73,"phone":353,"phoneExt":19,"email":19},"+256485660468",{"facility":355,"status":79,"city":356,"state":357,"zip":358,"country":344,"countryCode":345,"cosmosGeoPoint":19,"geoPoint":19,"contacts":359},"Infectious Diseases Institute Kalangala ( Site 0063)","Kalangala District","Kalangala","30060\u002F+256",[360],{"name":87,"role":73,"phone":361,"phoneExt":19,"email":19},"+256312211482",{"facility":363,"status":79,"city":364,"state":365,"zip":366,"country":344,"countryCode":345,"cosmosGeoPoint":367,"geoPoint":371,"contacts":372},"MU-JHU Research Collaboration - Mityana ( Site 0061)","Mityana, District","Mityana","30026\u002F+256",{"type":109,"coordinates":368},[369,370],32.02278,0.4175,{"lat":370,"lon":369},[373],{"name":87,"role":73,"phone":374,"phoneExt":19,"email":19},"+25760334881",{"facility":376,"status":79,"city":341,"state":377,"zip":378,"country":344,"countryCode":345,"cosmosGeoPoint":379,"geoPoint":381,"contacts":382},"UVRI Clinical Research Program Initiative Ltd (UVRI CRP) ( Site 0067)","Wakiso","30006",{"type":109,"coordinates":380},[348,349],{"lat":349,"lon":348},[383],{"name":87,"role":73,"phone":384,"phoneExt":19,"email":19},"+256312216100",{"facility":386,"status":79,"city":387,"state":19,"zip":388,"country":344,"countryCode":345,"cosmosGeoPoint":389,"geoPoint":393,"contacts":394},"MU-JHU Research Collaboration - Kampala ( Site 0062)","Kampala","10216\u002F+256",{"type":109,"coordinates":390},[391,392],32.58219,0.31628,{"lat":392,"lon":391},[395],{"name":87,"role":73,"phone":396,"phoneExt":19,"email":19},"+256703419772",{"type":398,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100598448","phase-3-a-study-of-mk-8527-to-prevent-human-immunodeficiency-virus-type-1-hiv-1-mk-8527-010-100598448",false,"NCT07071623","A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)","A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis in Women","Inclusion Criteria:\n\nThe main inclusion criteria include but are not limited to the following:\n\n* Is confirmed Human Immunodeficiency Virus (HIV)-uninfected based on negative HIV-1\u002FHIV-2 test results\n* Has been sexually active (2 vaginal intercourse encounters with cisgender male individual(s) within the last 3 months)\n* Was assigned female sex at birth and is cisgender.\n* Weighs ≥35 kg\n\nExclusion Criteria:\n\nThe main exclusion criteria include but are not limited to the following:\n\n* Has hypersensitivity or other contraindication to any component of the study interventions\n* Has evidence of acute or chronic hepatitis B infection\n* Has a history of malignancy within 5 years of screening except for adequately treated basal cell or squamous cell skin cancer, or in situ cervical cancer\n* Has taken cabotegravir, lenacapavir, or any other long-acting HIV prevention product at any time\n* Is receiving or is anticipated to require any prohibited therapies from 30 days prior to Day 1 through the study duration\n* Has received an HIV vaccine at any time (ie, through past participation in an investigational clinical study) or monoclonal antibodies to HIV within 12 months before Day 1",true,"FEMALE","16 Years","30 Years",{"count":411,"type":412},4580,"ESTIMATED","INTERVENTIONAL",[415],"PHASE3","Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection.\n\nThe goals of this study are to learn:\n\n* If taking MK-8527 once a month works to prevent HIV-1 infection better than a standard (usual) pre-exposure prophylaxis (PrEP) taken once a day\n* About the safety of MK-8527 and if people tolerate it",[418,419],"Human Immunodeficiency Virus (HIV)","HIV Pre-Exposure Prophylaxis","2026-08-21",{"date":422,"type":423},"2026-08-24","ACTUAL",{"date":425,"type":423},"2025-11-10",{"date":427,"type":412},"2027-10-18",{"name":5,"class":6},30]